CUAMC
DMAC icon

China Universal Asset Management Company’s DiaMedica Therapeutics DMAC Stock Holding History

China Universal Asset Management Company’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.9K Buy
5,000
+1,400
+39% +$11.1K ﹤0.01% 477
2025
Q4 		$28.7K Buy
+3,600
New +$26.9K ﹤0.01% 479

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

China Universal Asset Management Company's DMAC Position: Q1 2026 in Review

China Universal Asset Management Company increased its DiaMedica Therapeutics (DMAC) stake by 39% in Q1 2026, buying an estimated $11.1K and bringing the position to 5,000 shares worth $33.9K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

China Universal Asset Management Company first reported a position in DMAC in Q4 2025 and has held it in 2 quarters since. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • China Universal Asset Management Company held 5,000 shares of DiaMedica Therapeutics worth $33.9K as of Q1 2026.
  • China Universal Asset Management Company bought 1,400 DiaMedica Therapeutics shares in Q1 2026, an estimated $11.1K.
  • DiaMedica Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q1 2026, its #477 holding.
  • China Universal Asset Management Company first reported a position in DiaMedica Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.